Sarepta Therapeutics, Inc.
SRPT stock score: 36/100
$18.18 · -2.05% · Scored Oct 22, 2026
- Technical
- 35
- Fundamental
- 37
- News
- 38
The reading
Sarepta Therapeutics (SRPT) scores 36 out of 100, which reads bearish, higher than 21% of Healthcare stocks and 11% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 35, fundamentals 37.
Among the fundamentals, Revenue Growth (5-Year) at 100 and Institutional Ownership at 100 score highest, while Earnings Growth (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 46 and contrarian oscillators 45.
News sentiment is negative at 38; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 29 to 44, and it is up 7 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward SRPT’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
37Pulling it up
- Revenue Growth (5-Year)100
5-year revenue growth analyzes long-term sales trajectory and consistency.
- Institutional Ownership100
Institutional ownership measures the percentage held by professional investors.
- Current Ratio98
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- Earnings Growth (Quarterly)0
Quarterly earnings growth measures profit increase versus the prior-year quarter.
- Earnings Growth (Annual)0
Annual earnings growth tracks year-over-year profit expansion.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
41 weighted scorers.
Technical · daily
44Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- Candlestick Patterns100
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
- SMA 20 Cross Up83
SMA 20 Cross Up tracks when very short-term averages cross above the 20-period SMA.
Holding it back
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- SMA 50 Cross Up9
SMA 50 Cross Up detects when faster averages cross above the 50-period SMA.
- S&P 500 52W Comparison15
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 38
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 42 | 1 |
| Daily | 44 | 3 |
| Weekly | 35 | 2 |
| Monthly | 26 | 2 |
| Quarterly | 28 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 36 |
| Oct 21, 2026 | 38 |
| Oct 20, 2026 | 39 |
| Oct 19, 2026 | 35 |
| Oct 18, 2026 | 33 |
| Oct 17, 2026 | 33 |
| Oct 16, 2026 | 33 |
| Oct 15, 2026 | 35 |
| Oct 14, 2026 | 33 |
| Oct 13, 2026 | 33 |
| Oct 12, 2026 | 34 |
| Oct 11, 2026 | 36 |
| Oct 10, 2026 | 36 |
| Oct 9, 2026 | 36 |
| Oct 8, 2026 | 36 |
| Oct 7, 2026 | 34 |
| Oct 6, 2026 | 33 |
| Oct 5, 2026 | 33 |
| Oct 4, 2026 | 34 |
| Oct 3, 2026 | 34 |
| Oct 2, 2026 | 34 |
| Oct 1, 2026 | 33 |
| Sep 30, 2026 | 36 |
| Sep 29, 2026 | 37 |
| Sep 28, 2026 | 36 |
| Sep 27, 2026 | 36 |
| Sep 26, 2026 | 36 |
| Sep 25, 2026 | 37 |
| Sep 24, 2026 | 38 |
| Sep 23, 2026 | 40 |
| Sep 22, 2026 | 42 |
| Sep 21, 2026 | 41 |
| Sep 20, 2026 | 40 |
| Sep 19, 2026 | 40 |
| Sep 18, 2026 | 40 |
| Sep 17, 2026 | 41 |
| Sep 16, 2026 | 40 |
| Sep 15, 2026 | 41 |
| Sep 14, 2026 | 41 |
| Sep 13, 2026 | 40 |
| Sep 12, 2026 | 40 |
| Sep 11, 2026 | 42 |
| Sep 10, 2026 | 41 |
| Sep 9, 2026 | 43 |
| Sep 8, 2026 | 42 |
| Sep 7, 2026 | 43 |
| Sep 6, 2026 | 43 |
| Sep 5, 2026 | 43 |
| Sep 4, 2026 | 43 |
| Sep 3, 2026 | 44 |
| Sep 2, 2026 | 43 |
| Sep 1, 2026 | 43 |
| Aug 31, 2026 | 43 |
| Aug 30, 2026 | 43 |
| Aug 29, 2026 | 43 |
| Aug 28, 2026 | 43 |
| Aug 27, 2026 | 43 |
| Aug 26, 2026 | 41 |
| Aug 25, 2026 | 40 |
| Aug 24, 2026 | 38 |
| Aug 23, 2026 | 41 |
| Aug 22, 2026 | 41 |
| Aug 20, 2026 | 43 |
| Aug 19, 2026 | 44 |
| Aug 18, 2026 | 40 |
| Aug 17, 2026 | 41 |
| Aug 16, 2026 | 40 |
| Aug 15, 2026 | 40 |
| Aug 14, 2026 | 41 |
| Aug 13, 2026 | 42 |
| Aug 12, 2026 | 41 |
| Aug 11, 2026 | 41 |
| Aug 10, 2026 | 40 |
| Aug 9, 2026 | 39 |
| Aug 8, 2026 | 39 |
| Aug 7, 2026 | 42 |
| Aug 6, 2026 | 41 |
| Aug 5, 2026 | 40 |
| Aug 3, 2026 | 39 |
| Aug 2, 2026 | 37 |
| Jul 31, 2026 | 44 |
| Jul 30, 2026 | 44 |
| Jul 29, 2026 | 44 |
| Jul 28, 2026 | 39 |
| Jul 27, 2026 | 40 |
| Jul 26, 2026 | 29 |
| Jul 25, 2026 | 29 |
Key facts
- Market cap
- $1.9B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.38
- Risk grade (1–10)
- 6
- Next earnings
- Nov 5, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| VCEL Vericel | $2.2B | 58 |
| IMNM Immunome | $2.2B | 41 |
| PHVS Pharvaris | $2.2B | 42 |
| HRMY Harmony Biosciences | $2.1B | 68 |
| VERA Vera Therapeutics | $2.1B | 36 |
| ZYME Zymeworks | $2.0B | 52 |
Questions
What is SRPT's stock score today?
SRPT scores 36/100 (Bearish) as of Oct 22, 2026: technical 35, fundamental 37, and news sentiment 38, which is shown but not counted. Scores are recomputed every night.
Is SRPT a buy?
The score is not a buy or sell recommendation. A 36 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the SRPT score calculated?
103 weighted scorers feed it today: 41 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.